Register now for the 2023 ISPE Facilities of the Future Conference, a one-of-a-kind event exploring advancements in technologies and what pharmaceutical manufacturing facilities will look like in the future. Join us 31...
ISPE announced seven keynote speakers for the 2022 ISPE Annual Meeting & Expo , taking place 30 October–2 November 2022 in Orlando, Florida, and virtually. This signature event brings together top pharmaceutical industry and regulatory leaders...
The 2022 ISPE Pharma 4.0™ and Annex 1 Conference brings together leading pharmaceutical and biopharmaceutical manufacturers, technology providers, academic scientists, and international regulators. At the conference, you...
The 2022 ISPE Biotechnology Conference will focus on themes to level up agility in the new normal. Register now today to learn what’s in store for the future of biopharmaceutical manufacturing, examining how companies...
Register for the ISPE Expert Xchange: Regulatory Summit on ICH Q9 Revision on 9 June from 1000–1330 ET to learn from and collaborate with global regulators—including members of the ICH Q9(R1) Expert Working Group. Get a...
The past two years have seen unprecedented innovations in the development and manufacturing of pharmaceuticals. Sessions, panel discussions, and workshops at the 2022 ISPE Annual Meeting & Expo will provide you with...
ISPE announced Juan Andres, Chief Technical Operations and Quality Officer of Moderna, Inc., as the confirmed closing keynote speaker for the 2022 ISPE Biotechnology Conference , taking place 28-30 June 2022 in Boston, Massachusetts and virtually...
Taking place 25–27 April 2022 in Madrid, Spain, the 2022 ISPE Europe Annual Conference will explore sustainability, Annex 1, digital quality, trends in pharmaceutical engineering, and project management during 50+...
The 2022 ISPE Facilities of the Future Conference will explore advancements in pharmaceutical technology and what pharmaceutical manufacturing facilities will look like in the future. 1–2 Feb 2022 Hybrid Conference North...
Lou Kennedy, CEO and Owner Nephron Pharmaceuticals Under Kennedy’s leadership, Nephron has experienced unprecedented growth. The company is now nearly 2,000 employees strong and produces more than 1 billion doses of life...
